Intensity Therapeutics Statistics
Total Valuation
INTS has a market cap or net worth of $11.59 million. The enterprise value is $2.16 million.
| Market Cap | 11.59M |
| Enterprise Value | 2.16M |
Important Dates
The next estimated earnings date is Thursday, November 5, 2026, after market close.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
INTS has 3.26 million shares outstanding. The number of shares has increased by 273.56% in one year.
| Current Share Class | 3.26M |
| Shares Outstanding | 3.26M |
| Shares Change (YoY) | +273.56% |
| Shares Change (QoQ) | +6.82% |
| Owned by Insiders (%) | 4.45% |
| Owned by Institutions (%) | 22.11% |
| Float | 3.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.10 |
| P/TBV Ratio | 1.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.00, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.00 |
| Quick Ratio | 4.24 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -195.88% and return on invested capital (ROIC) is -123.55%.
| Return on Equity (ROE) | -195.88% |
| Return on Assets (ROA) | -89.91% |
| Return on Invested Capital (ROIC) | -123.55% |
| Return on Capital Employed (ROCE) | -123.79% |
| Weighted Average Cost of Capital (WACC) | 21.02% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.59M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.29% in the last 52 weeks. The beta is 3.08, so INTS's price volatility has been higher than the market average.
| Beta (5Y) | 3.08 |
| 52-Week Price Change | -49.29% |
| 50-Day Moving Average | 4.08 |
| 200-Day Moving Average | 5.84 |
| Relative Strength Index (RSI) | 40.64 |
| Average Volume (20 Days) | 16,259 |
Short Selling Information
The latest short interest is 31,298, so 0.96% of the outstanding shares have been sold short.
| Short Interest | 31,298 |
| Short Previous Month | 48,911 |
| Short % of Shares Out | 0.96% |
| Short % of Float | 1.03% |
| Short Ratio (days to cover) | 1.05 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -11.48M |
| Pretax Income | -11.16M |
| Net Income | -11.16M |
| EBITDA | n/a |
| EBIT | -11.48M |
| Earnings Per Share (EPS) | -$4.80 |
Balance Sheet
The company has $9.53 million in cash and $95,000 in debt, with a net cash position of $9.43 million or $2.89 per share.
| Cash & Cash Equivalents | 9.53M |
| Total Debt | 95,000 |
| Net Cash | 9.43M |
| Net Cash Per Share | $2.89 |
| Equity (Book Value) | 9.21M |
| Book Value Per Share | 3.13 |
| Working Capital | 8.98M |
Cash Flow
| Operating Cash Flow | -8.95M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | n/a |
| Net Borrowing | n/a |
| Free Cash Flow | -8.95M |
| FCF Per Share | -$2.74 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
INTS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -273.56% |
| Shareholder Yield | -273.56% |
| Earnings Yield | -94.64% |
| FCF Yield | -75.91% |
Analyst Forecast
The average price target for INTS is $19.33, which is 444.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.33 |
| Price Target Difference | 444.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on February 19, 2026. It was a reverse split with a ratio of 1:25.
| Last Split Date | Feb 19, 2026 |
| Split Type | Reverse |
| Split Ratio | 1:25 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |